CRL
Price
$150.01
Change
-$1.58 (-1.04%)
Updated
Jun 27 closing price
Capitalization
13.96B
30 days until earnings call
MOVE
Price
$0.67
Change
-$0.02 (-2.90%)
Updated
Jun 30, 12:30 PM (EDT)
Capitalization
24.5M
Interact to see
Advertisement

CRL vs MOVE

Header iconCRL vs MOVE Comparison
Open Charts CRL vs MOVEBanner chart's image
Charles River Laboratories International
Price$150.01
Change-$1.58 (-1.04%)
Volume$814.66K
Capitalization13.96B
Movano
Price$0.67
Change-$0.02 (-2.90%)
Volume$1K
Capitalization24.5M
CRL vs MOVE Comparison Chart in %
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. MOVE commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Buy and MOVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CRL: $150.01 vs. MOVE: $0.69)
Brand notoriety: CRL and MOVE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 70% vs. MOVE: 11%
Market capitalization -- CRL: $13.96B vs. MOVE: $24.5M
CRL [@Medical Specialties] is valued at $13.96B. MOVE’s [@Medical Specialties] market capitalization is $24.5M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileMOVE’s FA Score has 1 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • MOVE’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRL and MOVE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while MOVE’s TA Score has 4 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 5 bearish.
  • MOVE’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, MOVE is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а +1.74% price change this week, while MOVE (@Medical Specialties) price change was +2.48% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.38%. For the same industry, the average monthly price growth was +1.94%, and the average quarterly price growth was +2.76%.

Reported Earning Dates

CRL is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+2.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than MOVE($24.5M). CRL YTD gains are higher at: -18.738 vs. MOVE (-87.313). CRL has higher annual earnings (EBITDA): 1.03B vs. MOVE (-31.4M). CRL has more cash in the bank: 277M vs. MOVE (7.67M). MOVE has less debt than CRL: MOVE (204K) vs CRL (3.07B). CRL has higher revenues than MOVE: CRL (4.13B) vs MOVE (0).
CRLMOVECRL / MOVE
Capitalization14B24.5M57,143%
EBITDA1.03B-31.4M-3,287%
Gain YTD-18.738-87.31321%
P/E Ratio29.15N/A-
Revenue4.13B0-
Total Cash277M7.67M3,612%
Total Debt3.07B204K1,502,941%
FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRLMOVE
RSI
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 20 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
64%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TPOR25.300.37
+1.48%
Direxion Dly Transp Bull 3X Shrs ETF
FEGE40.170.07
+0.17%
FIRST EAGLE GLOBAL EQUITY ETF
BKHY48.13-0.01
-0.02%
BNY Mellon High Yield ETF
PHEQ30.55-0.01
-0.03%
Parametric Hedged Equity ETF
GTO46.74-0.04
-0.09%
Invesco Total Return Bond ETF

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RVTY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-1.04%
RVTY - CRL
63%
Loosely correlated
-0.98%
NOTV - CRL
59%
Loosely correlated
-7.61%
IQV - CRL
59%
Loosely correlated
-0.44%
A - CRL
59%
Loosely correlated
-0.21%
ICLR - CRL
58%
Loosely correlated
-1.49%
More

MOVE and

Correlation & Price change

A.I.dvisor tells us that MOVE and INSP have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MOVE and INSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOVE
1D Price
Change %
MOVE100%
-4.25%
INSP - MOVE
29%
Poorly correlated
+2.08%
CRL - MOVE
28%
Poorly correlated
-1.04%
NOTV - MOVE
28%
Poorly correlated
-7.61%
A - MOVE
27%
Poorly correlated
-0.21%
MTD - MOVE
26%
Poorly correlated
-0.73%
More